Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
ResMed Inc. (NYSE: RMD)
RMD Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
15.10%
Analyst Rating:
BUY
Analyst Forecast (1yr):
53.70%
RMD Stock Analysis
RMD
PE Ratio:
18
RMD
PEG Ratio:
1.9
RMD
Forward EPS Growth (12 month):
9.60%
RMD
PS Ratio:
4.9
RMD
PSG Ratio:
0.7
RMD
Forward Revenue Growth (12 month):
7.40%
RMD Articles
No data was found